A detailed history of Paloma Partners Management CO transactions in Insmed Inc stock. As of the latest transaction made, Paloma Partners Management CO holds 177 shares of INSM stock, worth $12,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177
Previous 240 26.25%
Holding current value
$12,613
Previous $16,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $3,906 - $4,977
-63 Reduced 26.25%
177 $12,000
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $5,280 - $16,730
240 New
240 $16,000
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $79,643 - $104,500
-3,546 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $85,706 - $127,691
3,546 New
3,546 $101,000
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $184,359 - $459,613
-13,526 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $218,039 - $337,879
13,526 New
13,526 $323,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.